Versant Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.9K Buy
473
+255
+117% +$7.53K ﹤0.01% 2079
2026
Q1
$5.4K Buy
218
+205
+1,577% +$4.88K ﹤0.01% 2357
2025
Q4
$303 Hold
13
﹤0.01% 2607
2025
Q3
$256 Hold
13
﹤0.01% 2598
2025
Q2
$282 Hold
13
﹤0.01% 2580
2025
Q1
$315 Hold
13
﹤0.01% 2442
2024
Q4
$271 Hold
13
﹤0.01% 2318
2024
Q3
$258 Hold
13
﹤0.01% 1944
2024
Q2
$201 Hold
13
﹤0.01% 1905
2024
Q1
$207 Hold
13
﹤0.01% 1828
2023
Q4
$219 Hold
13
﹤0.01% 1856
2023
Q3
$152 Hold
13
﹤0.01% 1899
2023
Q2
$175 Buy
+13
New +$187 ﹤0.01% 2001

Other funds holding CPRX